Disorder of sex development 46,XY associated with mutations in the gene MAP3K1. The report of clinical cases
https://doi.org/10.14341/probl8596
Abstract
The disorders of sex development (DSD) 46,XY may be caused by mutations in a number of genes involved in the gonadal differentiation. The XY sex inversion can be also due to disturbances at the level of mitogen-activated protein kinase (MAPK) kinase kinase 1 gene (MAP3K1) and MAPK-signaling pathway. During the last decade, the involvement of the MAPK pathway in the SRY gene up-regulation during the formation of male gonadal sex in mammals has been demonstrated. The role of MAPK-signaling pathway in the human sex determination is not fully understood. Probably, MAP3K1 and the MAPK-signaling pathway are one of the genetic pathways controlling normal development of human testis. So far, several families and sporadic cases of 46,XY DSD due to mutations in MAP3K1 gene have been reported in the literature. Clinical presentation of DSD in these patients varies from female phenotype with normal externalia to male phenotype with hypospadias. We describe rare cases of the DSD 46,XY (a family case of DSD in uterine sisters and a sporadic case) with mutations in the MAP3K1 gene that haven’t been previously described. The article also presents brief literature review on this pathology.
About the Authors
Irina V. KopylovaEndocrinology Research Centre
Russian Federation
MD, PhD
Elena S. Kuznetsova
Endocrinology Research Centre
Russian Federation
MD
Igor S. Chugunov
Endocrinology Research Centre
Russian Federation
MD, PhD
Elizaveta M. Orlova
Endocrinology Research Centre
Russian Federation
MD, PhD
Oleg S. Danilenko
Endocrinology Research Centre
Russian Federation
MD, PhD
Dmitry N. Brovin
Endocrinology Research Centre
Russian Federation
MD, PhD
Maria A. Kareva
Endocrinology Research Centre
Russian Federation
MD, PhD
Valentina A. Peterkova
Endocrinology Research Centre
Russian Federation
MD, PhD, Professor
References
1. Hughes IA, Houk C, Ahmed Sf, et al. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-563. doi: 10.1136/Adc.2006.098319
2. Jost A, Vigier B, Prepin J, Perchellet Jp. Studies on sex differentiation in mammals. Recent Prog Horm Res. 1973;29:1-41.
3. Bashamboo A, Mcelreavey K. Human sex-determination and disorders of sex-development (DSD). Semin Cell Dev Biol. 2015;45:77-83. doi: 10.1016/J.Semcdb.2015.10.030
4. Pearlman A, Loke J, Le Caignec C, et al. Mutations in Map3k1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 2010;87(6):898-904. doi: 10.1016/J.Ajhg.2010.11.003
5. Das DK, Rahate SG, Mehta BP, et al. Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development. Indian J Hum Genet. 2013;19(4):437-442. doi: 10.4103/0971-6866.124372
6. Karandikar M, Xu S, Cobb Mh. MEKK1 binds raf-1 and the ERK2 cascade components. J Biol Chem. 2000;275(51):40120-40127. doi: 10.1074/Jbc.M005926200
7. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153-183. doi: 10.1210/Edrv.22.2.0428
8. Roberts PJ, Der CJ. Targeting rhe Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291-3310. doi: 10.1038/Sj.Onc.1210422
9. Bogani D, Siggers P, Brixey R, et al. Loss of mitogen-activated protein kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. Plos Biol. 2009;7(9):E1000196. doi: 10.1371/Journal.Pbio.1000196
10. Gierl MS, Gruhn WH, Von Seggern A, et al. GADD45G functions in male sex determination by promoting p38 signaling and Sry expression. Dev Cell. 2012;23(5):1032-1042. doi: 10.1016/J.Devcel.2012.09.014
11. Warr N, Carre GA, Siggers P, et al. GADD45gamma and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry Expression. Dev Cell. 2012;23(5):1020-1031. doi: 10.1016/J.Devcel.2012.09.016
12. Szczepankiewicz A, Sobkowiak P, Rachel M, et al. Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma. 2012;49(4):329-335. doi: 10.3109/02770903.2012.669442
13. Warr N, Bogani D, Siggers P, et al. Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP31K1. Plos One. 2011;6(5):E19572. doi: 10.1371/Journal.Pone.0019572
14. Charlaftis N, Suddason T, Wu X, et al. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. Embo J. 2014;33(21):2581-2596. doi: 10.15252/Embj.201488351
Supplementary files
|
1. Рисунок 1. Семейный анамнез пациенток с нарушение формирования пола 46,XY. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(39KB)
|
Indexing metadata ▾ |
|
2. Family history of patients with impaired sex formation 46, XY. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(45KB)
|
Indexing metadata ▾ |
Review
For citations:
Kopylova I.V., Kuznetsova E.S., Chugunov I.S., Orlova E.M., Danilenko O.S., Brovin D.N., Kareva M.A., Peterkova V.A. Disorder of sex development 46,XY associated with mutations in the gene MAP3K1. The report of clinical cases. Problems of Endocrinology. 2018;64(1):45-49. https://doi.org/10.14341/probl8596

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).